Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 267

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation

Open access
Gammie, James S., Chu, Michael W.A., Falk, Volkmar, Overbey, Jessica R., Moskowitz, Alan J., Gillinov, Marc, Mack, Michael J., Voisine, Pierre, Krane, Markus, Yerokun, Babatunde, Bowdish, Michael E., Conradi, Lenard, Bolling, Steven F., Miller, Marissa A., Taddei-Peters, Wendy C., Jeffries, Neal O., Parides, Michael K., Weisel, Richard, Jessup, Mariell, Rose, Eric A., Mullen, John C., Raymond, Samantha, Moquete, Ellen G., O’Sullivan, Karen, Marks, Mary E., Iribarne, Alexander, Beyersdorf, Friedhelm, Borger, Michael A., Geirsson, Arnar, Bagiella, Emilia, Hung, Judy, Gelijns, Annetine C., O’Gara, Patrick T., Ailawadi, Gorav · 2022 · New England Journal of Medicine

Abstract

BACKGROUND: Tricuspid regurgitation is common in patients with severe degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform tricuspid-valve repair during mitral-valve surgery in patients who have moderate tricuspid regurgitation or less-than-moderate regurgitation with annular dilatation. METHODS: We randomly assigned 401 patients who were undergoing mitral-valve surgery for degenerative mitral regurgitation to receive a procedure with or without tricuspid annuloplasty (TA). The primary 2-year end point was a composite of reoperation for tricuspid regurgitation, progression of tricuspid regurgitation by two grades from baseline or the presence of severe tricuspid regurgitation, or death. RESULTS: Patients who underwent mitral-valve surgery plus TA had fewer primary-end-point events than those who underwent mitral-valve surgery alone (3.9% vs. 10.2%) (relative risk, 0.37; 95% confidence interval [CI], 0.16 to 0.86; P = 0.02). Two-year mortality was 3.2% in the surgery-plus-TA group and 4.5% in the surgery-alone group (relative risk, 0.69; 95% CI, 0.25 to 1.88). The 2-year prevalence of progression of tricuspid regurgitation was lower in the surgery-plus-TA group than in the surgery-alone group (0.6% vs. 6.1%; relative risk, 0.09; 95% CI, 0.01 to 0.69). The frequencies of major adverse cardiac and cerebrovascular events, functional status, and quality of life were similar in the two groups at 2 years, although the incidence of permanent pacemaker implantation was higher in the surgery-plus-TA group than in the surgery-alone group (14.1% vs. 2.5%; rate ratio, 5.75; 95% CI, 2.27 to 14.60). CONCLUSIONS: Among patients undergoing mitral-valve surgery, those who also received TA had a lower incidence of a primary-end-point event than those who underwent mitral-valve surgery alone at 2 years, a reduction that was driven by less frequent progression to severe tricuspid regurgitation. Tricuspid repair resulted in more frequent permanent pacemaker implantation. Whether reduced progression of tricuspid regurgitation results in long-term clinical benefit can be determined only with longer follow-up. (Funded by the National Heart, Lung, and Blood Institute and the German Center for Cardiovascular Research; ClinicalTrials.gov number, NCT02675244.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2115961

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 267

Metadata

Authors
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B., Bowdish, M. E., Conradi, L., Bolling, S. F., Miller, M. A., Taddei-Peters, W. C., Jeffries, N. O., Parides, M. K., Weisel, R., Jessup, M., Rose, E. A., Mullen, J. C., Raymond, S., Moquete, E. G., O’Sullivan, K., Marks, M. E., Iribarne, A., Beyersdorf, F., Borger, M. A., Geirsson, A., Bagiella, E., Hung, J., Gelijns, A. C., O’Gara, P. T., & Ailawadi, G.
Venue
New England Journal of Medicine
Published
2022-01-27
Volume
386
Issue
4
Pages
327-339
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3214238244
Cited by
267
References
25
FWCI
26.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. https://app.cochat.ai/papers/10.1056/nejmoa2115961
The paper
Gammie, J. S., Chu, M. W. A., Falk, V., Overbey, J. R., Moskowitz, A. J., Gillinov, M., Mack, M. J., Voisine, P., Krane, M., Yerokun, B., Bowdish, M. E., Conradi, L., Bolling, S. F., Miller, M. A., Taddei-Peters, W. C., Jeffries, N. O., Parides, M. K., Weisel, R., Jessup, M., . . . Ailawadi, G. (2022). Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2115961

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.